Royal Capital Wealth Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,665	Closed	-$18.9K	–	99
2023 Q4	$18.9K	Buy	+10,665	New	+$18.9K	0.02%	92